National Health Investors (NHI) to Release Earnings on Thursday

National Health Investors (NYSE:NHI) is anticipated to announce its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $1.23 per share and revenue of $95.1210 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Friday, February 27, 2026 at 10:00 AM ET.

National Health Investors Stock Down 2.2%

Shares of NYSE NHI opened at $88.98 on Thursday. The stock has a market capitalization of $4.24 billion, a PE ratio of 28.07, a P/E/G ratio of 3.11 and a beta of 0.66. The company has a quick ratio of 10.64, a current ratio of 10.64 and a debt-to-equity ratio of 0.74. The firm has a fifty day moving average of $80.21 and a 200-day moving average of $78.04. National Health Investors has a 52-week low of $66.41 and a 52-week high of $91.38.

Analysts Set New Price Targets

NHI has been the subject of several research analyst reports. Wells Fargo & Company upped their price target on National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. Cantor Fitzgerald set a $85.00 price target on shares of National Health Investors in a report on Monday, January 5th. KeyCorp lifted their price target on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th. Truist Financial increased their price objective on shares of National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research report on Monday, December 15th. Finally, National Bank Financial set a $85.00 target price on shares of National Health Investors in a report on Tuesday, January 20th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $85.57.

Institutional Investors Weigh In On National Health Investors

A number of large investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its position in National Health Investors by 244.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of National Health Investors in the fourth quarter worth about $33,000. Advisory Services Network LLC purchased a new position in National Health Investors in the third quarter valued at about $65,000. Triumph Capital Management purchased a new position in National Health Investors in the third quarter valued at about $66,000. Finally, NewEdge Advisors LLC grew its stake in National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.